Detalhe da pesquisa
1.
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer.
Haematologica
; : 0, 2023 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37855029
2.
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Ann Intern Med
; 174(10): 1420-1429, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34516270
3.
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
; 42(17): 1698-1706, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33760027
4.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
N Engl J Med
; 378(7): 615-624, 2018 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29231094
5.
Clinical implications of incidental venous thromboembolism in cancer patients.
Eur Respir J
; 55(2)2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31727694
6.
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Lancet
; 388(10055): 1995-2003, 2016 Oct 22.
Artigo
Inglês
| MEDLINE | ID: mdl-27590218
7.
Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.
Circulation
; 131(1): 82-90, 2015 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-25403645
8.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
N Engl J Med
; 369(15): 1406-15, 2013 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-23991658
9.
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Vasc Med
; 21(4): 361-8, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27165711
10.
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal.
Crit Care
; 20(1): 273, 2016 Sep 23.
Artigo
Inglês
| MEDLINE | ID: mdl-27659071
11.
Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study.
J Thromb Haemost
; 21(10): 2929-2940, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37178771
12.
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.
Clin Pharmacol Drug Dev
; 11(5): 666-674, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34877813
13.
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.
J Am Coll Cardiol
; 80(24): 2301-2310, 2022 12 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36328157
14.
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.
Eur Heart J Cardiovasc Pharmacother
; 8(7): 695-706, 2022 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34962979
15.
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.
Res Pract Thromb Haemost
; 6(5): e12748, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35992565
16.
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
J Thromb Haemost
; 19(12): 3008-3017, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34455706
17.
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.
Res Pract Thromb Haemost
; 5(5): e12566, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34278193
18.
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
J Thromb Haemost
; 19(11): 2801-2813, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34379859
19.
Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial.
Thromb Res
; 195: 209-214, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32750571
20.
The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease.
Res Pract Thromb Haemost
; 4(5): 886-892, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32685899